Microencapsulation market is projected to grow at a CAGR of 13.85% during the forecast period, reaching a total market size of US$27.209 billion in 2024 from US$12.494 billion in 2018. Microencapsulation is widely used in the healthcare and pharmaceutical sector for controlled drug delivery. Microencapsulation technologies are extensively used by pharmaceutical companies to mask the bitter taste or smell in drugs and to provide targeted delivery and controlled delivery. The demand for microencapsulated biomolecules is increasing in the pharmaceutical industry as well as the agriculture industry due to functions like effective and targeted delivery of the active ingredients. With the rising adoption of the technology by small and medium scale end users, it is further expected to drive the demand in microencapsulation market.
The major players profiled in the Microencapsulation market include Watson Inc., AVEKA, Inc., MIKROCAPS, Capsularis, Givaudan, Koehler Innovative Solutions, Prinova, and Orbis Biosciences, Inc.
The Microencapsulation market has been analyzed through the following segments:
Middle East and Africa